Dose-escalation of oxaliplatin in hemodialysis patient treated with FOLFOX therapy: A case report

RATIONALE: Oxaliplatin is a key part of the standard treatment for colorectal cancer which is formally contraindicated in patients with severe renal dysfunction. Here, we investigated a safe and efficient dosing schedule of oxaliplatin in folinic acid, fluorouracil, and oxaliplatin (FOLFOX) regimen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Danping, Li, Xiaofei, Xu, Lingyan, Fang, Wentong, Cai, Xiaomin, Wang, Ying, Wang, Jiawei, Wang, Yuanyuan, Zhao, Fengjiao, Gu, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946187/
https://www.ncbi.nlm.nih.gov/pubmed/31689749
http://dx.doi.org/10.1097/MD.0000000000017462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946187/
https://www.ncbi.nlm.nih.gov/pubmed/31689749
http://dx.doi.org/10.1097/MD.0000000000017462

Ejemplares similares